Market closed
ResMed/$RMD
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About ResMed
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Ticker
$RMD
Sector
Trading on
NYSE
Industry
Health Care Equipment & Supplies
Headquarters
Employees
9,980
Website
ResMed Metrics
BasicAdvanced
$35B
Market cap
32.04
P/E ratio
$7.54
EPS
0.69
Beta
$1.97
Dividend rate
0.88%
Dividend yield
Price and volume
Market cap
$35B
Beta
0.69
52-week high
$252.80
52-week low
$150.39
Average daily volume
1.1M
Dividend rate
$1.97
Financial strength
Current ratio
2.921
Quick ratio
1.369
Long term debt to equity
15.632
Total debt to equity
16.366
Dividend payout ratio (TTM)
26.02%
Interest coverage (TTM)
40.70%
Management effectiveness
Return on assets (TTM)
13.27%
Return on equity (TTM)
23.56%
Valuation
Price to earnings (TTM)
32.036
Price to revenue (TTM)
7.384
Price to book
6.82
Price to tangible book (TTM)
19.37
Price to free cash flow (TTM)
26.356
Dividend yield (TTM)
0.82%
Forward dividend yield
0.88%
Growth
Revenue change (TTM)
9.88%
Earnings per share change (TTM)
22.60%
3-year revenue growth (CAGR)
12.81%
3-year earnings per share growth (CAGR)
30.25%
3-year dividend per share growth (CAGR)
6.74%
What the Analysts think about ResMed
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for ResMed stock.
ResMed Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
ResMed Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
ResMed News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Market closed
Upcoming events
Dec
12
ResMed
Dividend·Payment
$0.53
Per share
FAQs
What’s the current market cap for ResMed stock?
ResMed (RMD) has a market cap of $35B as of November 21, 2024.
What is the P/E ratio for ResMed stock?
The price to earnings (P/E) ratio for ResMed (RMD) stock is 32.04 as of November 21, 2024.
Does ResMed stock pay dividends?
Yes, the ResMed (RMD) stock pays dividends to shareholders. As of November 21, 2024, the dividend rate is $1.97 and the yield is 0.88%. ResMed has a payout ratio of 26.02% on a trailing twelve-month basis.
When is the next ResMed dividend payment date?
The next ResMed (RMD) dividend payment is scheduled for December 12, 2024.
What is the beta indicator for ResMed?
ResMed (RMD) has a beta rating of 0.69. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.